Abstract: |
Human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC) is an epidemiologically, pathologically, and clinically distinct form of cancer of the head and neck. It is associated with a significantly better prognosis and overall survival than its HPV-negative counterpart. Patients presenting with this disease are usually younger, healthier, and without the usual risk factors of aerodigestive tract malignancy such as significant smoking or alcohol use. As such, there has been a focus on reducing treatment toxicities and optimizing quality of life while maintaining favorable oncologic outcomes. This chapter provides the rationale behind de-intensification strategies, an overview of approaches to de-intensification and limitations to de-intensification. © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2022. |